These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2159120)

  • 1. Supersensitivity of GABA-A receptors in hepatic encephalopathy.
    Baraldi M
    Neurochem Res; 1990 Feb; 15(2):153-60. PubMed ID: 2159120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
    Zeneroli ML
    J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD; Olasmaa M
    Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
    Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M
    Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
    Yurdaydin C; Gu ZQ; Nowak G; Fromm C; Holt AG; Basile AS
    J Pharmacol Exp Ther; 1993 May; 265(2):565-71. PubMed ID: 8388453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2005 Dec; 20(4):425-37. PubMed ID: 16382352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.
    Butterworth RF
    J Steroid Biochem Mol Biol; 2016 Jun; 160():94-7. PubMed ID: 26589093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy.
    Zeneroli ML; Baraldi M; Ventura E; Vezzelli C; Tofanetti O; Germini M; Casciarri I
    Life Sci; 1991; 48(1):37-50. PubMed ID: 1846016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy.
    Maddison JE; Dodd PR; Morrison M; Johnston GA; Farrell GC
    Hepatology; 1987; 7(4):621-8. PubMed ID: 3038721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand.
    Basile AS; Gammal SH; Jones EA; Skolnick P
    J Neurochem; 1989 Oct; 53(4):1057-63. PubMed ID: 2549194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of hepatic encephalopathy.
    Jones EA
    Clin Liver Dis; 2000 May; 4(2):467-85. PubMed ID: 11232201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.
    Olasmaa M; Rothstein JD; Guidotti A; Weber RJ; Paul SM; Spector S; Zeneroli ML; Baraldi M; Costa E
    J Neurochem; 1990 Dec; 55(6):2015-23. PubMed ID: 2172467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current theories on the pathogenesis of hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
    Albrecht J; Jones EA
    J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
    Schafer DF; Fowler JM; Munson PJ; Thakur AK; Waggoner JG; Jones EA
    J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand.
    Basile AS; Ostrowski NL; Gammal SH; Jones EA; Skolnick P
    Adv Biochem Psychopharmacol; 1990; 46():189-200. PubMed ID: 1963266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.
    Meyer HP; Legemate DA; van den Brom W; Rothuizen J
    Metab Brain Dis; 1998 Sep; 13(3):241-51. PubMed ID: 9804368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.